ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1055

Expansions of Salivary Gland CD4+ T Cells from Sjögren’s Syndrome Patients: Single-Cell Repertoire Analysis and Correlation with Clinical Measures of Disease

Michelle L. Joachims1, Kerry M. Leehan2,3, Christina M. Lawrence3, Astrid Rasmussen3, Lida Radfar4, David M. Lewis5, Glen D Houston6, Kiely Grundahl3, Donald U. Stone7,8, Kimberly Hefner9, R. Hal Scofield2,10,11, Kathy L. Sivils2,3, Linda F. Thompson12 and A. Darise Farris1,2, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Oral Diagnosis and Radiology Department, University of Oklahoma Health Sciences Center College of Dentistry, Oklahoma City, OK, 5College of Dentistry, Department of Oral and Maxillofacial Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 6Heartland Pathology, Oklahoma City, OK, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 9Hefner Eye Care and Optical Center, Oklahoma City, OK, 10College of Medicine, Section of Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 11Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 12Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Sjogren's syndrome, T cells and salivary gland

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Sjögren's Syndrome I: Basic Insights

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:   CD4+ T cells predominate in salivary gland (SG) focal lymphocytic infiltrates in primary Sjögren’s syndrome (pSS).  However, their antigen specificity, degree of clonal expansion and relationship to clinical disease features remain unknown.  Here, we determined the T cell receptor (TCR) repertoire of CD4+ memory T cells in SG and peripheral blood (PB) of pSS patients and assessed whether the frequencies of clonally expanded SG T cells correlate with specific measures of disease.

Methods:   Multiplex single cell RT-PCR was used to amplify both the α and β TCR sequences from individual memory CD4+ T cells sorted from SG lip biopsy tissue and PB of 10 patients fulfilling both the 2002 Revised American European Consensus Group Criteria and the 2012 Provisional ACR Criteria for pSS.  Percentages of T cells that were part of SG clonal expansions were calculated and correlated with various measures of disease.  

Results:   Over 3,000 TCR sequences were obtained from 50-115 (median 91) individual SG and 75-121 (median 108) individual PB CD4+ memory T cells per patient. The percentages of cells that were part of clonal expansions were significantly higher in SG (median 12%, range 0-28%) compared to PB (median 0.9%, range 0-7%, p=0.002). The TCR sequences of expanded memory CD4+ T cells in SG were largely distinct from those in PB and were enriched for cells expressing dual productive TCRα transcripts (χ2=4.42, p=0.036).  Sequence analysis revealed:   1) highly homologous CDR3s among different expanded SG T cell clones within single patients, suggesting antigen-driven expansion and 2) unique cases of convergent recombination among unrelated patients, where different V segments/additions/deletions were utilized to make identical CDR3 amino acid sequences.  The percentages of clonally expanded CD4+ memory T cells in SG correlated significantly with reduced whole unstimulated salivary flow (r=-0.758, p=0.015) and increased degree of SG fibrosis (r=0.661, p=0.044) but not with systemic features of disease. 

Conclusion: SG clonal expansions detected in this study likely identify T cells involved in recognition of common antigen(s) and glandular dysfunction.


Disclosure: M. L. Joachims, None; K. M. Leehan, None; C. M. Lawrence, None; A. Rasmussen, None; L. Radfar, None; D. M. Lewis, None; G. D. Houston, None; K. Grundahl, None; D. U. Stone, None; K. Hefner, None; R. H. Scofield, None; K. L. Sivils, None; L. F. Thompson, None; A. D. Farris, None.

To cite this abstract in AMA style:

Joachims ML, Leehan KM, Lawrence CM, Rasmussen A, Radfar L, Lewis DM, Houston GD, Grundahl K, Stone DU, Hefner K, Scofield RH, Sivils KL, Thompson LF, Farris AD. Expansions of Salivary Gland CD4+ T Cells from Sjögren’s Syndrome Patients: Single-Cell Repertoire Analysis and Correlation with Clinical Measures of Disease [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/expansions-of-salivary-gland-cd4-t-cells-from-sjogrens-syndrome-patients-single-cell-repertoire-analysis-and-correlation-with-clinical-measures-of-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expansions-of-salivary-gland-cd4-t-cells-from-sjogrens-syndrome-patients-single-cell-repertoire-analysis-and-correlation-with-clinical-measures-of-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology